Medical technology industry invited into innovation debate:
This article was originally published in Clinica
The healthcare technology industry is being encouraged to participate in the next session of the World Health Organization's Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG). All interested parties have until September 30 2007 to "propose solutions aimed at fostering innovation for the creation of new products against diseases that disproportionately affect poor and marginalised populations". Contributors are asked to submit a summary of their comments (maximum 500 words) to a dedicated website (www.who.int/phi/public- hearings/second) in any of the six official UN languages - namely Arabic, Chinese, English, French, Russian or Spanish. These comments will form part of the documentation that will be discussed at the IGWG's second session, which is being hosted by the WHO during November 5-10.
You may also be interested in...
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.